Status:
COMPLETED
Risk of Air Contamination During Visceral Surgery in COVID19 Patients
Lead Sponsor:
University Hospital, Lille
Conditions:
Sars-CoV2
Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sars-Cov2 has been found in the digestive tract, as well as the respiratory tract. Protection of health care workers during surgery has been increased and some guidelines advocate for abandoning lapar...
Eligibility Criteria
Inclusion
- Documented Sars-Cov2 infection (nasopharyngeal swab, tracheal sampling, thoracic CT, serology)
- Need of visceral surgery (laparoscopy or laparotomy)
- Signed informed consent
- Social coverage
- Patient who agrees to be included in the study and who signs the informed consent form
- Patient affiliated to a healthcare insurance plan
- Patient willing to comply with study's requirements
Exclusion
- Need of another type of surgery during the same procedure
- Mentally unbalanced patients, under supervision or guardianship
- Patient who does not understand French/ is unable to give consent
- Patient not affiliated to a French or European healthcare insurance
- Patient incarcerated
Key Trial Info
Start Date :
November 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 27 2022
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04395599
Start Date
November 16 2021
End Date
January 27 2022
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hop Claude Huriez Chu Lille
Lille, France, 59037